Biologics sponsors are encouraged to follow established, voluntary standards when developing new products, the Food and Drug Administration (FDA) said in new draft guidance it issued on Dec. 19 (82 Fed. Reg. 60,204).
Study the topic in more depth in the AAPS book Regulated Bioanalysis: Fundamentals and Practice.
To read the full content, please log in with your AAPS member username and password.
Sign InNot a member? Learn more and join today!
AAPS Magazine helps pharmauceutical scientists excel in their jobs by providing current science, news, career advice, member recognition, AAPS offerings, and other valuable contemporary information.
2107 Wilson Blvd #700
Arlington, VA 22201
AAPS Customer Service